OXT and breast cancer: Cassoni et al. reported that oxytocin release blocks this mitogenic effect via the cAMP-PKA pathway, because cAMP levels increase upon the addition of oxytocin, while PKA inhibitors block the anti-mitogenic effect of oxytocin in breast cancer cell lines [26].